PSTV News and Press, PLUS THERAPEUTICS Inc. From 11/03/23

2023-11-03 12:14:31 ET DENVER, Colo., Nov. 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Werewolf Therapeutics Inc (NASDAQ: HOWL), Plus Therapeutics Inc (NASDAQ: PSTV), Tenon Medical Inc (...

2023-11-03 10:05:39 ET Volatility and Opportunity with Penny Stocks Penny stocks , also known as micro-cap equities or stocks under $5 per share, offer investors affordable opportunities. This is to buy shares in emerging small companies early before potential growth and upside. How...

2023-11-03 09:53:11 ET DENVER, Colo., Nov. 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Werewolf Therapeutics Inc (NASDAQ: HOWL), Plus Therapeutics Inc (NASDAQ: PSTV), Tenon Medical Inc (NASDAQ: TNO...

2023-11-03 07:34:30 ET More on Plus Therapeutics Plus Therapeutics, Inc. (PSTV) Q3 2023 Earnings Call Transcript Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript Biocept gains on licensing pact with Plus Therapeutics for cancer test Seeking Alp...

2023-11-03 07:27:34 ET DENVER, Colo., Nov 3, 2023 ( www.247marketnews.com )- Plus Therapeutics, Inc. (Nasdaq: PSTV) stated, this morning, that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to rhenium (186Re) obisbemeda for the treatment of breast ...

AUSTIN, Texas, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today annou...

2023-10-31 19:46:02 ET Plus Therapeutics, Inc. (PSTV) Q3 2023 Earnings Conference Call October 31, 2023, 5:00 PM ET Corporate Participants Marc Hedrick - President and Chief Executive Officer Andrew Sims - Vice President and Chief Financial Officer Norman LaFranc...

2023-10-31 16:17:53 ET More on Plus Therapeutics Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript Biocept gains on licensing pact with Plus Therapeutics for cancer test Seeking Alpha’s Quant Rating on Plus Therapeutics Historical earning...

2023-10-31 16:11:19 ET More on Plus Therapeutics Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript Biocept gains on licensing pact with Plus Therapeutics for cancer test Seeking Alpha’s Quant Rating on Plus Therapeutics Historical earning...

New survival data from 15 patients in the Phase 2 ReSPECT-GBM trial of rhenium ( 186 Re) obisbemeda in recurrent glioblastoma (rGBM) will be presented at SNO Annual Meeting on November 17 th ; Company will also host a Key Opinion Leader (KOL) event following the meeting to...